Peter Antony Barbuti

Adjunct Professor

Fordham University

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Peter Antony Barbuti is an Adjunct Professor at Fordham University in the United States. His research focuses on the molecular mechanisms underlying neurodegenerative diseases, particularly Parkinson's disease and amyotrophic lateral sclerosis. Recent publications explore topics such as mitochondrial function, alpha-synuclein's role in synucleinopathy, and advancements in stem-cell-derived therapies for neurological disorders.

Articles (10)

Year:

2025

Year:

2025

Year:

2024

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (8)

Olaf Riess

University of Tuebingen

GERMANY

View details

Lorraine V. Kalia

CANADA

View details

Chang Liu

University of Hohenheim

GERMANY

View details

Maeve Caldwell

Professor

Trinity College Dublin

IRELAND

View details

LUCY CROMPTON

SENIOR LECTURER NEUROSCIENCES

University of the West of England

UNITED KINGDOM

View details

Stella Papa

UNITED STATES

View details

Talitha Kerrigan

Associate Professor

University of Exeter

UNITED KINGDOM

View details

Hideki Mochizuki

Professor

Osaka University

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Peter Antony Barbuti

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Author Correction: Mitochondria interaction networks show altered topological patterns in Parkinson’s disease

The role of alpha-synuclein in synucleinopathy: Impact on lipid regulation at mitochondria–ER membranes

A-Syn(ful) MAM: A Fresh Perspective on a Converging Domain in Parkinson’s Disease

Intronic enhancers of the human SNCA gene predominantly regulate its expression in brain in vivo

DYT6 mutated THAP1 is a cell type dependent regulator of the SP1 family

Retromer dysfunction in amyotrophic lateral sclerosis.

Recent Advances in the Development of Stem‐Cell‐Derived Dopaminergic Neuronal Transplant Therapies for Parkinson's Disease

Gene-corrected p.A30P SNCA patient-derived isogenic neurons rescue neuronal branching and function

A monolayer hiPSC culture system for autophagy/mitophagy studies in human dopaminergic neurons

Mitochondria interaction networks show altered topological patterns in Parkinson’s disease

Collaborators (8)

Olaf Riess

Lorraine V. Kalia

Chang Liu

Maeve Caldwell

LUCY CROMPTON

Stella Papa

Talitha Kerrigan

Hideki Mochizuki

Make your next move.